The global blood processing devices market was valued at USD 54.2 billion in 2025. The market is projected to grow from USD 57.7 billion in 2026 to USD 99.2 billion by 2034, exhibiting a compound annual growth rate of 7.01% during the forecast period. Contrive Datum Insights presents this information in its report titled "Blood Processing Devices Market Size, Share & Industry Analysis, By Product (Blood Bags, Blood Collection Tubes, Needles & Syringes, Blood Collection Systems/Monitors, Lancets), Application (Blood Transfusion, Therapeutic Applications, Diagnostic and Research), End-user (Hospitals, Ambulatory Surgical Centers, & Nursing Homes, Diagnostic & Pathology Laboratories, Blood Banks, Others), Technology (Automated/Apheresis-Based Systems, Semi-Automated Systems, Manual/Gravity-Based Systems), Usage (Single-Use/Disposable, Reusable/Durable), and Regional Forecast, 2026-2034".
Blood processing devices comprise the equipment and consumables used to collect, separate, store, and monitor human blood and its components, including collection tubes, needles and syringes, collection bags, automated collection and monitoring systems, and lancets. Buyers span hospitals, ambulatory surgical centers and nursing homes, diagnostic and pathology laboratories, and blood banks that manage donor collection, component separation, and inventory for transfusion, therapeutic, and diagnostic use.
Rising global blood donation and transfusion volumes
Rising global blood donation and transfusion volumes is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.01% a year, the product lines exposed to it move fastest: Blood Collection Systems/Monitors compounds at 11.81%, taking its share of revenue from 16% to 24% and its value from USD 8.67 billion to USD 23.81 billion.
On the upside, the study's bull case assumes faster hospital and blood bank adoption of automated and apheresis-based collection systems combined with sustained growth in donation and therapeutic blood product volumes, which would take 2034 revenue to USD 108.13 billion against the USD 99.2 billion base case.
On the downside, slower replacement of manual collection equipment and tighter public health procurement budgets that delay device upgrades in cost-constrained markets, which would hold 2034 revenue to USD 90.97 billion. Blood Bags, which carries 30% of 2025 revenue, already grows at only 5.75% against the market's 7.01%, so the largest part of the base is also its slowest.
Blood Bags Scale Against Blood Collection Systems/Monitors Momentum
The product axis, not the regional one, is what divides the field. Blood Bags is the volume position, 30% of 2025 revenue at USD 16.26 billion, holding 27% through 2034, and it is defended by scale. Blood Collection Systems/Monitors is the growth position at 11.81%, and it is open. Strength in one does not carry into the other.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Blood Transfusion | 55% · USD 29.81 billion | Diagnostic and Research 8.31% |
| End-user | Hospitals, Ambulatory Surgical Centers, & Nursing Homes | 45% · USD 24.39 billion | Diagnostic & Pathology Laboratories 7.99% |
| Technology | Semi-Automated Systems | 35% · USD 18.97 billion | Automated/Apheresis-Based Systems 10.43% |
| Usage | Single-Use/Disposable | 78% · USD 42.28 billion | Reusable/Durable 7.99% |
- North America was the largest region in 2025, holding 37% of global revenue at USD 20.05 billion and reaching USD 33.73 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24% in 2025 to 29% in 2034, with revenue growing from USD 13.01 billion to USD 28.77 billion.
- At 6% of 2025 revenue and 6% by 2034, Middle East and Africa is the smallest region throughout.
- Blood Bags was the leading product line in 2025, taking 30% of revenue at USD 16.26 billion.
- The fastest product line is Blood Collection Systems/Monitors, forecast to compound at 11.81% through the period.
- The United States is the largest single country market at USD 17.04 billion in 2025, 31.4% of global revenue.
Coverage runs to five axes, by product, and by application, end-user, technology and usage, with a revenue figure and a growth rate for every line in every year from 2020 to 2034, and bear, base and bull cases on the headline total at USD 90.97 billion and USD 108.13 billion by 2034. All five regions are broken out to country level, alongside the competitive landscape and the methodology behind each estimate. The study is delivered as a PDF, and a free sample can be requested.